| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |